← Back to Search

Procedure

Quadriceps vs. Hamstring Autograft for ACL Rupture (SQuASH Trial)

N/A
Recruiting
Led By Darren de SA, MD, FRCSC
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Complete or partial transphyseal ACL femoral and tibial tunnel drilling/reconstruction techniques.
Males and females aged 10-18 years.
Must not have
Previous knee surgery in the affected or contra-lateral knee.
Generalized ligamentous laxity and/or hypermobility (i.e. Beighton Criteria ≥ 4/9), given statistically significant higher failure rates (24% vs. 7.7%) and inferior subjective outcomes in this population.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to compare the efficacy of soft-tissue quadriceps versus hamstring autograft tendons on re-operation, return to sport, and knee function among paediatric patients undergoing primary ACL reconstruction.

Who is the study for?
This trial is for boys and girls aged 10-18 who have had an ACL injury, speak the clinic's language, and can give informed consent. They must have been active in sports before their injury and be suitable for a specific type of knee surgery. Kids with very flexible joints, significant other health issues, or previous knee surgeries aren't eligible.
What is being tested?
The study compares two types of tendon grafts used in knee surgery to repair the ACL in kids: one from the hamstring (the current standard) and one from the quadriceps (a newer option). The goal is to see which graft leads to better surgery outcomes like fewer re-operations and improved knee function.
What are the potential side effects?
While not explicitly listed, potential side effects may include pain at the graft site, infection risk post-surgery, reduced range of motion or strength in the affected leg, complications related to anesthesia during surgery.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had ACL reconstruction with specific drilling techniques.
Select...
I am between 10 and 18 years old.
Select...
My ACL injury is confirmed by an MRI or arthroscopy.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had surgery on my knee or the opposite knee before.
Select...
I am very flexible or have loose joints, scoring 4 or more on the Beighton scale.
Select...
I had ACL surgery with a man-made graft.
Select...
I have issues with my knee's ligaments or cartilage.
Select...
My knee damage is confirmed by tests to be Grade 2 or higher.
Select...
I need daily help for personal care due to other health issues.
Select...
I have had surgery to repair my ACL.
Select...
My ACL surgery involved using donor tissue or a mix of my own and donor tissue.
Select...
I have a fracture in the front part of my shinbone.
Select...
I have had a previous injury to the growth plate in my knee.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Rate of reoperation
Secondary study objectives
Anterior Cruciate Ligament Integrity
Anterolateral Rotary Instability of the Knee
Incidence of distal femoral and/or proximal tibial/fibular physeal injury
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Soft-tissue hamstringActive Control1 Intervention
All patients in the study will undergo arthroscopic-assisted, single-bundle, complete transphyseal, anatomic primary ACL reconstruction at the discretion of the surgeon, considering the individual patient's age, physeal status, and anticipated years of growth remaining to skeletal maturity. Patients in this arm will undergo soft-tissue autograft reconstruction using hamstrings (i.e. semitendinosus and/or gracilis) grafts. Grafts will be secured on the femur and tibia according to surgeon preference, given literature demonstrating no clear superior method for graft fixation.
Group II: Quadriceps tendonActive Control1 Intervention
Patients in this arm will undergo soft-tissue autograft reconstruction using all-soft-tissue quadriceps (i.e. full or partial thickness) grafts. Grafts will be secured on the femur and tibia according to surgeon preference, given literature demonstrating no clear superior method for graft fixation.

Find a Location

Who is running the clinical trial?

McMaster UniversityLead Sponsor
918 Previous Clinical Trials
2,616,193 Total Patients Enrolled
Canadian Orthopaedic FoundationOTHER
14 Previous Clinical Trials
1,536 Total Patients Enrolled
The Physicians' Services Incorporated FoundationOTHER
163 Previous Clinical Trials
28,294 Total Patients Enrolled
Darren de SA, MD, FRCSCPrincipal InvestigatorMcMaster University

Media Library

Quadriceps tendon autograft (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT03896464 — N/A
Anterior Cruciate Ligament Rupture Research Study Groups: Soft-tissue hamstring, Quadriceps tendon
Anterior Cruciate Ligament Rupture Clinical Trial 2023: Quadriceps tendon autograft Highlights & Side Effects. Trial Name: NCT03896464 — N/A
Quadriceps tendon autograft (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03896464 — N/A
~17 spots leftby Jan 2026